Monthly Archives October 2008

Wound Management: Wound Prevalance, Treatment Trends

From Report #S245, “Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World,” published by MedMarket Diligence, LLC (November 2007).
Wound types fall into four general categories — surgical, traumatic, burns, and chronic — yet there is a wide variety of specific types, with different prevalence and [...]

Bleak outlook for safe(r) investment?

At the Musculoskeletal New Ventures Conference this week, hosted by the Memphis Bioworks Foundation and MB Venture Parters , a roundtable discussion was held including principals from EDF Ventures, the Vertical Group, and Thomas McNerny & Partners. The conclusion?  Investment looks bad for healthcare startups (Outlook Bleak for Investment in Health Care Startups).
With the credit [...]

Worldwide Ophthalmic Revenues Show Western Concentration

The following is an excerpt from the report, “Products, Technologies, Markets and Opportunities in Ophthalmology Surgical, Device and Drug Markets Worldwide, 2007,” Report #G125, from MedMarket Diligence.
Although a fair amount of consolidation has taken place among ophthalmology technology companies in the last half decade, a number of entrepreneurial firms have surfaced with promising innovations that [...]

New medtech startups, identified by name

As I am occasionally known to do, I am providing the list of actual company names recently identified as medtech startups (and included in the Medtech Startups Database).  See below:

Tissue Fusion, LLC (laser devices to “weld” biological tissues together for wound closures)
Applied Catheter Technologies, Inc. (drug-coated urinary and other catheters and stents that are designed [...]

Fibrin sealants reducing the incidence, extent and severity of anti-adhesion

Haemacure Corporation last month disclosed the apparent clinical utility of its fibrin sealant in the prevention of post-surgical adhesion:
Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, disclosed today the positive results of a second preclinical study conducted on the use of its [...]

Medtech startup formations economically immune?

There is certainly the possibility (despite my doubts) that the current economic slowdown in global markets will have major effects on the medical technology industry. One simply cannot deny that there is simply less VC or other cash floating around that might be put to medtech investment. And maybe, as has occurred in [...]

Asia-Pacific Markets for Spine Fusion Growing More Slowly

The markets which encompass Asia-Pacific are generally somewhat more mature markets which have seen these products and have been using these technologies. Hence, for spinal fusion, for example, the tendency away from fusion and towards intermediate treatments will be seen in the years to come.
Fusion markets in this region, at over $80 million annually in [...]

Slowdown will be weathered in medtech

The credit crunch that has morphed into a global recession, or at least generated enough fears of a recession to drive the stock market way down, is now raising questions like, “is anyone immune?”
Of course, some sectors are more immunoresistant to the investment squeeze than others, notably the healthcare field, putatively unperturbed as it is [...]

U.S. Will Increasingly Dominate (Unfortunately) the Worldwide Bariatric Device Market

The US and Canadian market for bariatric devices is growing at stunning rate, driven by an increasingly prevalent patient population, the increasing capability of physicians to perform bariatric procedures and a recognition by healthcare systems and third party payers to address the problem as a lynchpin for a condition that otherwise will drive up other, [...]